Genetics of Type 1 Diabetes in Chinese Adolescents and Youth
- Conditions
- Diabetes Mellitus
- Registration Number
- NCT01938365
- Lead Sponsor
- Shanghai Jiao Tong University School of Medicine
- Brief Summary
primary outcome: To explore the genetic susceptibility of diabetes in Chinese adolescent and youth.
secondary outcomes:
1. To classify diabetes by gene detection in Chinese adolescent and youth.
2. To make the relationship between genotype and clinic phenotype in type 1 diabetes.
3. To evaluate the effect of environmental factors (intestinal ecosystem)in the pathogenesis of diabetes.
- Detailed Description
Phase 1: Baseline investigation Aims: To explore genetic susceptibility of diabetes in Chinese adolescent and youth.
Subjects and Methods: 500 patients under diabetic conditions and sex,age-matched NGR Healthy control(2:1) will be enrolled ,all aged from 14-30 years old. A comprehensive examination including questionnaire, anthropometric measurements, biochemical analysis will be performed in each study participant. Diabetes should be diagnosed according to the WHO 1999 criteria,type 1 or type 2 diabetes diagnosed by clinical features recommended by International Society of Pediatric and Adolescent Diabetes ( ISPAD ).
Phase 2: Cohort follow-up Aims : To explore the association of genetic backgrounds and clinical characteristics in different types of diabetes in Chinese adolescent and youth.
Subjects and Methods: To recruit and follow up 200 newly diagnosed and genotyped patients for 3 years. Questionnaire, anthropometric measurements, biochemical analysis performed respectively at baseline,3,6,12,24,36 months after enrollment.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 500
- Age: 14- 30 years old
- Gender: males and females
- Race: han
- Diabetes diagnosed by WHO cafeteria (WHO1999)
- Living in east China area to minimize population stratification
- Secondary diabetes caused by other diseases or drugs
- Moderate to severe liver, kidney dysfunction, i.e. ALT/AST > 2.5 times the upper limit of normal range or Ccr < 25ml/min;
- Any other condition or major systemic diseases that the investigator feels would interfere with trial participation or evaluation of results.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Deterioration of pancreatic islet function 3 years
- Secondary Outcome Measures
Name Time Method Insulin dosage, HbA1c levels and evaluation of chronic complications 3 years
Trial Locations
- Locations (1)
Ruijin hospital, Shanghai Jiao-Tong University School of Medicine
🇨🇳Shanghai, Shanghai, China